Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer
Clinical trial NCT01460537 · COMPLETED
Trial details
- NCT number
- NCT01460537
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-18
- Primary completion
- 2015-07-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.